Intellectual Property And Emerging Technologies The New Biology

Author: Matthew Rimmer; Alison McLennan
Publisher: Edward Elgar Publishing
ISBN: 9781849802468
Published In: January 2012
Format: Hardback , 512 pages
Jurisdiction: International ? Disclaimer:
Countri(es) stated herein are used as reference only

Out of stock

Description
Contents
Author

Details

This unique and comprehensive collection investigates the challenges posed to intellectual property by recent paradigm shifts in biology. It explores the legal ramifications of emerging technologies, such as genomics, synthetic biology, stem cell research, nanotechnology, and biodiscovery.

Extensive contributions examine recent controversial court decisions in patent law – such as Bilski v. Kappos, and the litigation over Myriad’s patents in respect of BRCA1 and BRCA2 – while other papers explore sui generis fields, such as access to genetic resources, plant breeders’ rights, and traditional knowledge. The collection considers the potential and the risks of the new biology for global challenges – such as access to health-care, the protection of the environment and biodiversity, climate change, and food security. It also considers Big Science projects – such as biobanks, the 1000 Genomes Project, and the Doomsday Vault. The inter-disciplinary research brings together the work of scholars from Australia, Canada, Europe, the UK, and the US and involves not only legal analysis of case law and policy developments, but also historical, comparative, sociological, and ethical methodologies.

Intellectual Property and Emerging Technologies will appeal to policy-makers, legal practitioners, business managers, inventors, scientists, and researchers.

Preface

Introduction: Inventing Life: Intellectual Property and the New Biology
Alison McLennan and Matthew Rimmer

PART I: A HISTORY OF BIODISCOVERY
1. Of Plants, Pills and Patents: Circulating Knowledge
Eva Hemmungs Wirtén

PART II: MEDICINE, BIOTECHNOLOGY AND GENOMICS
2. Bilski v. Kappos and Biotechnology Patents: Back to the Future?
Yann Joly and Francis Hemmings

3. The Current State of Patent Eligibility of Medical and Biotechnology Inventions in the United States
Joshua D. Sarnoff

4. Patent Law, the Emerging Biotechnologies and the Role of Language in Subject-Matter Expansionism
Graham Dutfield

PART III: BIOBANKS, BIOINFORMATICS AND BIOBRICKS
5. Standards for Biobank Access and Intellectual Property
Dianne Nicol and Richard Gold

6. The 1000 Genomes Project
Donna M. Gitter

7. Building with BioBricks: Constructing a Commons for Synthetic Biology Research
Alison McLennan

PART IV: GENETICS, STEM CELLS AND NANOTECHNOLOGY
8. Regulating Gene Regulation: Patenting Small RNAs
Adam Bostanci, Jane Calvert and Pierre-Benoit Joly

9. Stem Cell Patents: Looking for Serenity
Amina Agovic

10. Cosmo, Cosmolino: Patent Law and Nanotechnology
Alison McLennan and Matthew Rimmer

PART V: BIODIVERSITY, FOOD SECURITY AND CLIMATE CHANGE
11. Patenting the Kakadu Plum and the Marjarla Tree: Biodiscovery, Intellectual Property and Indigenous Knowledge
Sarah Holcombe and Terri Janke

12. Climate-Ready Crops: Intellectual Property, Agriculture and Climate Change
Matthew Rimmer

13. The Doomsday Vault: Seed Banks, Food Security and Climate Change
Matthew Rimmer

Bibliography

Index

Edited by Matthew Rimmer, Australian Research Council Future Fellow, Associate Professor, The Australian National University College of Law and Associate Director, ACIPA and Alison McLennan, PhD candidate and Vice-Chancellor’s Scholar, The Australian National University College of Law, Australia